Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect

被引：1

作者：

Reid, Ian ^{[9
]}

Eisman, John ^{[8
]}

Bone, Henry ^{[7
]}

Hosking, David ^{[6
]}

McClung, Michael ^{[5
]}

Rizzoli, Rene ^{[4
]}

Resch, Heinrich ^{[3
]}

Verbruggen, Nadia ^{[2
]}

Hustad, Carolyn ^{[1
]}

DaSilva, Carolyn ^{[1
]}

Santora, Arthur ^{[1
]}

Ince, Avery ^{[1
]}

Lombardi, Antonio ^{[1
]}

机构：

[1] Merck Res Labs, Rahway, NJ USA

[2] Merck Res Labs, Brussels, Belgium

[3] St Vincent Hosp, Vienna, Austria

[4] Hop Cantonal Univ Geneva, Geneva, Switzerland

[5] Oregon Osteoporosis Ctr, Portland, OR USA

[6] City Hosp Nottingham, Nottingham, England

[7] Michigan Bone & Mineral Ctr, Detroit, MI USA

[8] UNSW, St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW, Australia

[9] Univ Auckland, Auckland 1, New Zealand

来源：

关键词：

D O I：

10.1016/j.bone.2010.01.065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S31 / S32

页数：2